Jay T Flatley is Chairman and Acting CEO of Zymergen Inc.
Person profile
Roles
Zymergen
Chairman and Acting CEO
Denali Therapeutics
Director
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Rivian Automotive, Inc. / DE
23 Jun 23
4
Denali Therapeutics Inc.
5 Jun 23
4
Zymergen Inc.
19 Oct 22
4
COHERENT INC
1 Jul 22
4
Rivian Automotive, Inc. / DE
8 Jun 22
4
Denali Therapeutics Inc.
6 Jun 22
4
Rivian Automotive, Inc. / DE
31 May 22
4
Zymergen Inc.
19 Nov 21
4
Rivian Automotive, Inc. / DE
17 Nov 21
3
Rivian Automotive, Inc. / DE
9 Nov 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Jun 23 | RIVN Rivian Automotive Inc - Ordinary Shares | Class A Common Stock | Grant | Acquire A | No | No | 0 | 18,208 | 0.00 | 119,784 |
1 Jun 23 | DNLI Denali Therapeutics | Common Stock | Grant | Acquire A | Yes | No | 0 | 4,216 | 0.00 | 340,529 |
1 Jun 23 | DNLI Denali Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 30.92 | 12,649 | 391.11 k | 12,649 |
19 Oct 22 | ZY Zymergen | Common Stock | Sale back to company | Dispose D | No | No | 0 | 144,789 | 0.00 | 0 |
19 Oct 22 | ZY Zymergen | Stock Options Common Stock | Sale back to company | Dispose D | No | No | 8.52 | 189,125 | 1.61 mm | 0 |
19 Oct 22 | ZY Zymergen | Stock Options Common Stock | Sale back to company | Dispose D | No | No | 12.33 | 1,520,000 | 18.74 mm | 0 |